scispace - formally typeset
M

Massimo Donadelli

Researcher at University of Verona

Publications -  96
Citations -  10208

Massimo Donadelli is an academic researcher from University of Verona. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 35, co-authored 89 publications receiving 8125 citations. Previous affiliations of Massimo Donadelli include Vision-Sciences, Inc. & Academy of Sciences of the Czech Republic.

Papers
More filters
Journal ArticleDOI

Regulation of succinate dehydrogenase and role of succinate in cancer

TL;DR: An extensive examination of the role of succinate in cancer development through the induction of epigenetic and metabolic alterations and the effects on epithelial to mesenchymal transition, cell migration and invasion, and angiogenesis is reported.
Journal ArticleDOI

UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells

TL;DR: It is demonstrated for the first time that UCP2 plays a role in autophagy regulation bringing new insights into mitochondrial uncoupling protein field.
Journal ArticleDOI

Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway.

TL;DR: Investigation of changes in global gene expression observed after treatment of different pancreatic cancer cell lines with the methylase inhibitor 5-aza-2′-deoxycytidine found increased p21WAF1 and gadd45A expression to be associated with the efficacy of the treatment and induction of interferon-related genes may correlate with activation of the IFN signalling pathway.
Journal ArticleDOI

Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation

TL;DR: It is demonstrated that TSA can effectively increase the drug sensitivity of all the cell lines studied and may represent an experimental basis for potential clinical application of HDAC inhibitors, in particular in association with drugs used in cancer clinical treatment, supporting the idea thatHDAC inhibitors could act as sensitizers for chemotherapy.
Journal ArticleDOI

Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells.

TL;DR: One prominent feature was the increased ratio between the levels of expression of pro-APoptotic and anti-apoptotic genes, which was confirmed in eight additional pancreatic cancer cell lines after treatment with TSA, suggesting that this event may be a strong determinant for the induction of apoptosis by TSA.